G
Genmab A/S (GMAB)
25.82
0.00 (0.00%)
Get all premium features to the best stock analysis tool
25.82
0.00 (0.00%)
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.02 | 6.05 | 10 | |
| Quick ratio | 2.01 | 5.63 | 10 | |
| Debt to Equity | 0.93 | 0.30 | 6.0 | |
| Debt to Assets | 0.42 | 1.04 | 5.0 | |
| Interest coverage | 5.52 | -16.91 | 10 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2.05B | 2.39B | 3.12B | 3.73B | 3.73B |
| Gross Profit | N/A | 2.31B | 2.92B | 3.42B | 3.49B |
| Operating Income | 891M | 772M | 1.02B | 1.25B | 1.25B |
| Net Income | 770M | 631M | 1.14B | 966M | 966M |
| EBITDA | 932M | 820M | 1.08B | 1.33B | 1.32B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 28.12 | -48.63 | 5.5 |
| Next quarter | 16.87 | -42.32 | 5.0 |
| Current year | 15.74 | -19.63 | 5.0 |
| Next year | 18.38 | 45.5 | 9.5 |
| Weighted average score | 6.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 3.92 | -92.23 | -92.29 | -46.15 | 1.8 |
| Y/Y | 14.77 | -94.36 | -94.14 | -25.08 | 2.8 |
| 3y average | 22.26 | 15.69 | 16.07 | 37.75 | 9.5 |
| 5y average | 21.2 | 14.78 | 15.65 | 21.7 | 9.3 |
| Weighted average score | 5.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 6.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Wide | 8.0 |
| Network effect | Narrow | 4.0 |
| Economies of scale | Medium | 6.0 |
| Weighted average score | 6.4 | |
Total debt $5.4B significantly exceeds cash reserves ($1.7B), raising financial stability concerns
Total current assets $2.9B exceed Total current liabilities $1.4B, highlighting excellent liquidity
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (6x) indicates the company easily manages its debt payments
The company generates positive free cash flow $288.0M, supporting its financial health